Roche (RHHBY) and Itamar Medical Inc. Move Forward in Developing EndoPAT™ for Pre-Clinical Longitudinal Studies
1/4/2012 6:22:14 AM
CAESAREA, Israel--(BUSINESS WIRE)--Itamar-Medical (TASE: ITMR), the world's leader of non-invasive devices for diagnosis of cardiovascular health, announced achievement of the next milestone of the international pharmaceutical company, Roche, to further develop the EndoPAT technology for pre-clinical trials. This is a continuation of the original announcement from December 2010.
comments powered by